Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
Location: United States, Pennsylvania, Wayne
Employees: 51-200
Total raised: $62M
Founded date: 2012
Investors 9
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 27.05.2016 | - | $20M | - | aislingcap... |
| 02.10.2014 | Series B | $21M | - | vcnewsdail... |
| 24.10.2012 | Series A | $21M | - | vcnewsdail... |
Mentions in press and media 14
| Date | Title | Description | Source |
| 07.12.2021 | Aclaris Therapeutics : Virtual R&D Day Presentation | EMPOWERING PATIENTS THROUGH KINOME INNOVATION Aclaris Therapeutics Virtual R&D Day The Produc... | marketscre... |
| 18.11.2021 | Aclaris Therapeutics : Overview - November 2021 | EMPOWERING PATIENTS THROUGH KINOME INNOVATION Company Overview November 2021 © Copyright 2021 Ac... | marketscre... |
| 27.05.2016 | Aclaris Therapeutics Announces $20.0 Million Private Placeme... | MALVERN, Pa., May 27, 2016 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-s... | aislingcap... |
| 18.08.2015 | Malvern biotech company files for $86M IPO | Aclaris Therapeutics, a Malvern biotech company that’s developing topical drugs for skin lesions, fi... | technical.... |
| 02.10.2014 | Aclaris Therapeutics Closes $21M Series B Financing | Aclaris Therapeutics, Inc., a Malvern, Pennsylvania-based specialty pharmaceutical company, closed o... | finsmes.co... |
| 02.10.2014 | Aclaris Therapeutics Closes $21M Series B | MALVERN, PA, Privately-held specialty pharmaceutical company, announced today that it has closed o... | vcnewsdail... |
| 02.01.2014 | Biopharma company raises $21.5M to treat inflammatory skin d... | LXR agonists have generated interest as a source of life science innovation with the potential to tr... | medcitynew... |
| 04.10.2013 | From gamification to personalized medicine, here’s a list of... | CardioReady (@CardioReady) is all about automated external defibrillators and helps customers evalua... | medcitynew... |
| 24.10.2012 | Aclaris Therapeutics Secures $21M Series A | MALVERN, PA, Privately held specialty pharmaceutical company dedicated to developing dermatologica... | vcnewsdail... |
| 24.10.2012 | Dermatology therapeutics firm is born with $21M series A rou... | Stephen Tullman, who was an executive chairman with Vicept, will be the chairman of Aclaris’ board. ... | medcitynew... |
Show more